Spyre Therapeutics (SYRE) stock analysis: de-risked pipeline, cash runway to H2 2028, and 2026–2027 Phase 2 catalysts in ...

"Start by leading from where you are. Take ownership, mentor others, and think beyond your own docket. Leadership is about ...

In cold weather, hot chocolate is one of the most soothing drinks out there, and a splash of the right type of liqueur can ...

This exploratory study in healthy young adults found that plasma sodium levels within the normal clinical range are ...

With the launch of an XRP ETF, market sentiment has picked up, and many crypto analysts are optimistic about XRP’s ...

At Multiple Sclerosis News Today, stories about the keto diet, myelin repair, and vitamin D topped this year's most-read list ...

It’s up to businesses to determine AI’s destiny—whether AI is used to shorten the traditional workday and improve work-life ...

When a biotech company announces positive Phase 3 trial results or receives FDA approval, the market reaction is often immediate and substantial. This is not just speculation. These milestones ...

Follow live coverage from Milwaukee Journal Sentinel reporters on Day 4 of the trial of Milwaukee County Circuit Court Judge Hannah Dugan.

Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...

In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...

This article explores three critical fronts shaping the future of IP: federal AI legislation and executive preemption, ...